PCD Foundation Program Overview
The PCD Foundation focuses it's efforts in three main areas:
- Program Area 1: Research
- Program Area 2: Education
- Program Area 3: Advocacy and Support
Program Area 1: RESEARCH
Program Goals
Research activities supported by the PCD Foundation promote understanding of disease pathophysiology and
progression in PCD to aid in the development of better therapies, improved health outcomes and, eventually,
to find a cure for PCD.
Program Activities
The PCD Foundation supports research in two ways:
Indirect Support:
The PCD Foundation supports funding to investigators and institutions that comes from
other organizations. This support includes endorsement letters for projects and/or
individual investigators, development and dissemination of educational materials to the
PCD community and encouraging PCD patient participation in endorsed projects.
Financial support for and participation in research conferences related to topics of
interest to the PCD community are another form of indirect support provided by the
PCD Foundation.
Direct Funding:
A primary goal of the PCD Foundation is to fund research projects identified by our
medical and scientific advisory boards and our patient community as priorities. We
have identified five main areas for foundation support:
- Genetics and Genotype/Phenotype Correlations. Genes code for proteins, proteins are the building blocks of the cilium.
Understanding the genetic processes involved in building and operating a cilium and its molecular motors will offer hope
for advancements in diagnosis, therapeutic intervention and, eventually, a cure for PCD.
- Nitric oxide in PCD. People with PCD exhale extremely low levels of nasal nitric oxide. This well documented phenomenon
in PCD is at odds with studies that demonstrate that NO levels rise in the presence of inflammation in other disorders.
Although this phenomenon was first recognized more than a decade ago, the pathophysiology of low nasal NO in PCD is still not
understood. Understanding the mechanism that leads to low nasal NO may provide clues to structural and functional impairments in PCD.
- Associated conditions. While most current clinical interest in PCD is related to respiratory manifestations of the disorder,
we are aware that there are non-respiratory complications in PCD that are of great concern to the PCD community. It is not clear
if these complications are related to ciliary proteins (see genetics) or are correlated in another fashion. Better understanding
of these conditions could potentially offer therapeutic options for PCD patients. We also believe this information can be beneficial
to understanding non-PCD respiratory disease and birth defects. Here are some examples of PCD-associated conditions:
- Conditions associated with ciliated epithelial tissues: polycystic kidney
disease; cystic disorders of the pancreas and liver; hydrocephalus and
ventriculomegaly.
- Conditions associated with ciliated non-epithelial tissues (e.g. retinitis
pigmentosa)
- Conditions associated with GI function and nutritional status
- Conditions related to organ placement, formation and function
- Therapeutic interventions in PCD. As we progress to better understanding of the genetics and pathophysiology
of PCD, it is likely that potential therapeutic targets will be identified. The PCD Foundation will support research in therapies
that promise improved health outcomes and quality of life for individuals with PCD.
- Fertility issues in PCD. Many, but not all, males with PCD appear to be subfertile or infertile. This is
thought to be due to defects in the structure and/or function of the sperm flagellum. However, recent evidence indicates
that sperm motility in PCD males may be impaired even when the structure appears to be intact and dynein proteins are present.
This interesting observation requires further research. Females with PCD may also have fertility issues, but the clinical
picture is far less clear than with the males. There are anecdotal reports of increased risk for ectopic pregnancy and
spontaneous abortion (miscarriage). Because the population is very small, however, it is unclear whether these anecdotal
reports represent a true pattern of increased risk for PCD females. This is an area requiring further study. We would
also like to pursue research into the role of IVF and other fertility intervention options for people with PCD.
Go to top
Program Area 2: EDUCATION
Program Goals
As the only patient advocacy group focused on PCD in North America, the PCD Foundation will provide up-to-date and
accurate information on research, treatments and other aspects of coping with PCD. Target audiences will include patients,
caregivers, physicians, researchers and allied health care providers, as well as the general public.
Program Activities
The PCD Foundation utilizes multiple resources to inform and engage our community, including:
Go to top
Program Area 3: ADVOCACY and SUPPORT
Program Goals
Raising awareness of PCD and ensuring access to appropriate resources for affected individuals are the primary
goals of the Advocacy and Support program.
Program Activities
Raising Awareness
Using local and national media, patient support networks and other public outlets, the PCD Foundation will create
opportunities to increase awareness of PCD and the need for funding for research in PCD and other rare diseases.
In addition, we will educate federal, state and local elected officials about issues of concern to individuals with
PCD and other chronic illnesses using letter-writing campaigns and face-to-face meetings.
Access to Care
In order to live full and productive lives, people with PCD need:
- Access to specialized health centers able to make the diagnosis and implement treatment,
- Insurance coverage for necessary medication, equipment and therapies
- Recognition of the special needs of the chronically ill and protection from educational or job-related bias due
to their chronic, genetic condition
The PCD Foundation provides services to address access to care issues including
providing templates for letters to support insurance coverage or to appeal denials, maintaining a referral database
of physicians familiar with the disorder, and petitioning for diagnostic codes and coverage for procedures specific to PCD.
Go to top
PCD Foundation · 10137 Portland Avenue South · Minneapolis, MN 55420 ·
(612)386-1261
Home
|
Site Map |
Contact Us